Lippincott Williams & Wilkins

SHERPA: Unknown

People

  1. Disa
    Disa
  2. Abu-Rustum
    Abu-Rustum
  3. Mehrara
    Mehrara
  4. Cordeiro
    Cordeiro
  5. Brennan
    Brennan
  6. Busam
    Busam
  7. Leitao
    Leitao
  8. Antonescu
    Antonescu
  9. Matros
    Matros
  10. Pastores
    Pastores

Groups

  1. Surgery (1689)
  2. Department of Medicine (1114)
  3. Department of Pathology and Laboratory Medicine (907)
  4. Survivorship Research (699)
  5. Solid Tumor Oncology Division (655)
  6. Gynecology Disease Management Team (578)
  7. Plastic and Reconstructive Surgery (479)
  8. GSK Faculty (419)
  9. Epidemiology and Biostatistics (386)
  10. Center for Pancreatic Cancer Research (365)
Search Within
Formats
  1. Journal Article (3864)
  2. Meeting Abstract (638)
  3. Book Section (325)
  4. Review (216)
  5. Editorial (118)
  6. Conference Paper (62)
  7. Correspondence (36)
  8. Guidelines (34)
  9. Miscellaneous (24)
  10. Research Letter (20)
  11. Book Whole (16)
Groups
  1. Surgery (1689)
  2. Department of Medicine (1114)
  3. Department of Pathology and Laboratory Medicine (907)
  4. Survivorship Research (699)
  5. Solid Tumor Oncology Division (655)
  6. Gynecology Disease Management Team (578)

More Groups

People
  1. Joseph Disa (175)
  2. Nadeem Abu-Rustum (164)
  3. Babak Mehrara (159)
  4. Peter Cordeiro (157)
  5. David Klimstra (154)
  6. Robert Soslow (151)

More People

Years
  1. 2025 (150)
  2. 2024 (250)
  3. 2023 (238)
  4. 2022 (223)
  5. 2021 (188)
  6. 2020 (225)

More Years

Publications
  1. American Journal of Surgical Pathology (646)
  2. Annals of Surgery (367)
  3. Plastic and Reconstructive Surgery (365)
  4. International Journal of Gynecological Cancer (344)
  5. Critical Care Medicine (218)
  6. Neurology (176)

More Publications

Results (5353)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 results of relacorilant + nabpaclitaxel in patients with recurrent, platinum-resistant ovarian cancer with and without prior bevacizumab
    Meeting Abstract

    Colombo, N.; Van Gorp, T.; Matulonis, U.; Oaknin, A.; Grisham, R.; Fleming, G.; Olawaiye, A.; Tudor, I. C.; Pashova, H.; Lorusso, D.
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Role of adjuvant therapy in intermediate-risk cervical cancer patients - SCCAN study sub-analysis
    Meeting Abstract

    Cibula, D.; Akilli, H.; van Lonkhuijzen, Lrcw; Fagotti, A.; Dostálek, L.; Ortiz, D. I.; Meydanli, M. M.; Abu-Rustum, N. R.; Odetto, D.; Landoni, F.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Outcomes of gynaecological cancer surgery during the COVID-19 pandemic: Results from the international, multicenter, prospective CovidSurg-Gynaecological Cancer study
    Meeting Abstract

    Fotopoulou, C.; Khan, T.; Bracinik, J.; Glasbey, J.; Abu-Rustum, N.; Chiva, L.; Fagotti, A.; Fujiwara, K.; Ghebre, R.; Gutelkin, M.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Germline pathogenic variants in DNA repair genes and endometrial cancer risk
    Meeting Abstract

    Gordhandas, S.; Rios-Doria, E.; Cadoo, K.; Catchings, A.; Maio, A.; Kemel, Y.; Manning-Geist, B.; Sia, T.; Roche, K. L.; Leitao, M.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Updated safety of lenvatinib + pembrolizumab vs treatment of physician's choice in patients with advanced endometrial cancer: Study 309/KEYNOTE-775
    Meeting Abstract

    Makker, V.; Colombo, N.; Casado Herráez, A.; Monk, B.; Mackay, H.; Santin, A.; Miller, D.; Moore, R.; Ray-Coquard, I.; Shapira-Frommer, R.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Molecular stratification of ovarian clear cell carcinoma predicts clinical outcomes
    Meeting Abstract

    Gordhandas, S.; Manning-Geist, B.; Hodgson, A.; Zhou, Q.; Iasonos, A.; Chi, D.; Momeni-Boroujeni, A.; Abu-Rustum, N.; Leitao, M.; Roche, K. L.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study
    Meeting Abstract

    Gien, L.; Enserro, D.; Block, M.; Waggoner, S.; Duska, L.; Hendrickson, A. W.; Thaker, P.; Backes, F.; Bottsford-Miller, J.; Muller, C.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical impact in patients with cervical cancer: Subgroup analysis of the SCCAN project
    Meeting Abstract

    Dostálek, L.; Benešová, K.; Klát, J.; Kim, S. H.; Falconer, H.; Kostun, J.; Ricardo, D. R.; Zapardiel, I.; Ortiz, D. I.; van Lonkhuijzen, L. R. C. W.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Overall survival results from Ariel3: A phase 3 randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma
    Meeting Abstract

    Coleman, R. L.; Oza, A.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J.; Clamp, A.; Scambia, G.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Effect of experiential communication skills education on graduate medical education trainees' communication behaviors: A systematic review
    Review

    Bylund, C. L.; Vasquez, T. S.; Peterson, E. B.; Ansell, M.; Bylund, K. C.; Ditton-Phare, P.; Hines, A.; Manna, R.; Ospina, N. S.; Wells, R.; more...
    Academic Medicine (2022)

    Fulltext@MSK | Save